Related Experiment Video
Updated: Apr 28, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
Published on: June 21, 2018
Parallel Single-Tissue Summary-Data Mendelian Randomization and Functional Validation Identify the ARRDC1 Promoter
Lesheng Wang1,2, Zhipeng Xu3, Gaomeng Luo1,2
1Department of Neurosurgery, Zhongnan Hospital of Wuhan University, Wuhan, Hubei, 430071, People's Republic of China.
Purpose:
Anxiety disorders are highly heritable, but their underlying genetic mechanisms remain poorly understood. This study aimed to identify and functionally characterize genes whose expression is causally linked to anxiety disorder risk by integrating the parallel single-tissue genetic data.
Methods:
We applied a parallel single-tissue summary-data-based Mendelian randomization (SMR) approach. This integrated large-scale anxiety disorder GWAS statistics with expression quantitative trait loci (eQTL) data from peripheral blood and 13 brain regions. The functional impact of a prioritized SNP (rs4494021) was tested via dual-luciferase reporter assay. The behavioral consequences were investigated by performing stereotaxic, lentivirus-mediated overexpression of ARRDC1 specifically in the mouse cerebellar hemisphere, followed by comprehensive behavioral testing.
Results:
The SMR analysis identified thirteen potential causal genes (ITIH3, ZKSCAN4, GNL3, SLC35C1, FNBP4, COPZ1, ATP5MC1, ITIH4, EHMT1, PTPMT1, ARRDC1, NEK4, and BTN3A2). Among them, ARRDC1 emerged as a significant gene, showing associations with anxiety disorders in blood, cerebellar hemisphere, and cerebellum. The risk allele of the promoter SNP rs4494021 significantly enhanced ARRDC1 transcriptional activity. Crucially, cerebellar overexpression of ARRDC1 in mice robustly induced anxiety-like behaviors, including reduced exploration in the open field test, decreased open-arm activity in the elevated plus maze, and increased avoidance in the light-dark box test.
Conclusion:
By bridging genetic epidemiology with molecular and behavioral validation, this study identifies ARRDC1 promoter SNP rs4494021 as a genetically associated marker for anxiety disorders and functionally validates that elevated cerebellar ARRDC1 expression contributes to anxiety pathogenesis. These findings establish ARRDC1 as a functionally supported risk gene and highlight a novel component of anxiety-related neurocircuitry.
More Related Videos
11:31Rapid Fractionation and Isolation of Whole Blood Components in Samples Obtained from a Community-based Setting
Published on: November 30, 2015
09:38Generalized Psychophysiological Interaction PPI Analysis of Memory Related Connectivity in Individuals at Genetic Risk for Alzheimer's Disease
Published on: November 14, 2017
Related Concept Videos
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...
Human Genetics
The complex relationship between genetics and psychology is observable through common biological components such...
Social Anxiety Disorder
Single Nucleotide Polymorphisms-SNPs
Generalized Anxiety Disorder
Panic Disorder